Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel C Chung

Showing results (151-160 of 177) with videos related to

Pageof 18
Sort By:
Science Translational Medicine|February 11, 2012
AAV2 gene therapy readministration in three adults with congenital blindnessJean Bennett, Manzar Ashtari, Jennifer Wellman, et al.
Cancer Research|July 16, 2010
Transplanting normal vascular proangiogenic cells to tumor-bearing mice triggers vascular remodeling and reduces hypoxia in tumorsJunpei Sasajima, Yusuke Mizukami, Yoshiaki Sugiyama, et al.
JAMA|June 14, 2024
Germline CDH1 Variants and Lifetime Cancer RiskCarrie E Ryan, Grace-Ann Fasaye, Amber F Gallanis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II studyChristopher G Willett, Dan G Duda, Emmanuelle di Tomaso, et al.
Nature Communications|May 18, 2025
Single-cell transcriptomic characterization of microscopic colitisStefan Halvorsen, Molly Thomas, Mari Mino-Kenudson, et al.
American Journal of Ophthalmology|October 1, 2018
The Natural History of Inherited Retinal Dystrophy Due to Biallelic Mutations in the RPE65 GeneDaniel C Chung, Mette Bertelsen, Birgit Lorenz, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 2, 2009
Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib TrialMonica M Bertagnolli, Craig J Eagle, Ann G Zauber, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 26, 2024
Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric CancerChi-Lee C Ho, Michael B Gilbert, Guillaume Urtecho, et al.
Ophthalmology|June 17, 2022
Adeno-Associated Virus Serotype 2-hCHM Subretinal Delivery to the Macula in Choroideremia: Two-Year Interim Results of an Ongoing Phase I/II Gene Therapy TrialTomas S Aleman, Rachel M Huckfeldt, Leona W Serrano, et al.
Lancet (London, England)|July 5, 2016
Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trialJean Bennett, Jennifer Wellman, Kathleen A Marshall, et al.
Pageof 18

Showing results (151-160 of 177) with videos related to

Sort By:
Pageof 18
Science Translational Medicine|February 11, 2012
AAV2 gene therapy readministration in three adults with congenital blindnessJean Bennett, Manzar Ashtari, Jennifer Wellman, et al.
Cancer Research|July 16, 2010
Transplanting normal vascular proangiogenic cells to tumor-bearing mice triggers vascular remodeling and reduces hypoxia in tumorsJunpei Sasajima, Yusuke Mizukami, Yoshiaki Sugiyama, et al.
JAMA|June 14, 2024
Germline CDH1 Variants and Lifetime Cancer RiskCarrie E Ryan, Grace-Ann Fasaye, Amber F Gallanis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II studyChristopher G Willett, Dan G Duda, Emmanuelle di Tomaso, et al.
Nature Communications|May 18, 2025
Single-cell transcriptomic characterization of microscopic colitisStefan Halvorsen, Molly Thomas, Mari Mino-Kenudson, et al.
American Journal of Ophthalmology|October 1, 2018
The Natural History of Inherited Retinal Dystrophy Due to Biallelic Mutations in the RPE65 GeneDaniel C Chung, Mette Bertelsen, Birgit Lorenz, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 2, 2009
Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib TrialMonica M Bertagnolli, Craig J Eagle, Ann G Zauber, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 26, 2024
Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric CancerChi-Lee C Ho, Michael B Gilbert, Guillaume Urtecho, et al.
Ophthalmology|June 17, 2022
Adeno-Associated Virus Serotype 2-hCHM Subretinal Delivery to the Macula in Choroideremia: Two-Year Interim Results of an Ongoing Phase I/II Gene Therapy TrialTomas S Aleman, Rachel M Huckfeldt, Leona W Serrano, et al.
Lancet (London, England)|July 5, 2016
Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trialJean Bennett, Jennifer Wellman, Kathleen A Marshall, et al.
Pageof 18